1. Caphosol® IFU. EUSA Pharma (Europe) Limited, November 2008
2. Papas AS et al. Bone Marrow Transplant 2003;31:705–712
3. Haas M et al. 50th ASTRO congress 2008; abstract 2530

This website contains information about Oral Mucositis and the use of Caphosol for the prevention and treatment of Oral Mucositis
Caphosol is a class I medical device, marked CE

©EUSA Pharma (Europe) Ltd. May 2009. All rights reserved. www.eusapharma.com
Registered in England 4555273 Registered Office The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA Vat Registration No: 896 1192 88

www.caphosol.eu